Medicare utilization — CHRISTOPHER VAN NGUYEN (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2785 | Injection, regadenoson, 0.1 mg | 1,840 | 461 | $0 | $79,314 |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,575 | 779 | $0 | $16,188 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 1,273 | 599 | $0 | $110,208 |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 469 | 448 | $0 | $66,791 |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 463 | 453 | $0 | $275,630 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·